Clinical Trial Results:
Experimental Human Rhinovirus Infection, a randomized placebo-controlled pilot study
Summary
|
|
EudraCT number |
2012-004938-42 |
Trial protocol |
NL |
Global completion date |
28 Jun 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Jan 2021
|
First version publication date |
28 Jan 2021
|
Other versions |
|
Summary report(s) |
Short-term repeated HRV-16 exposure results in an attenuated immune response in vivo in humans |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.